Cargando…
Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein
BACKGROUND: Although the founding members of the INhibitor of Growth (ING) family of histone mark readers, ING1 and ING2, were defined as tumour suppressors in animal models, the role of other ING proteins in cellular proliferation and cancer progression is unclear. METHODS: We transduced ex vivo be...
Autores principales: | McClurg, Urszula L, Nabbi, Arash, Ricordel, Charles, Korolchuk, Svitlana, McCracken, Stuart, Heer, Rakesh, Wilson, Laura, Butler, Lisa M, Irving-Hooper, Bronwyn Kate, Pedeux, Rémy, Robson, Craig N, Riabowol, Karl T, Binda, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846061/ https://www.ncbi.nlm.nih.gov/pubmed/29381681 http://dx.doi.org/10.1038/bjc.2017.447 |
Ejemplares similares
-
ING3 promotes prostate cancer growth by activating the androgen receptor
por: Nabbi, Arash, et al.
Publicado: (2017) -
Biological Functions of the ING Proteins
por: Dantas, Arthur, et al.
Publicado: (2019) -
ING Proteins: Tumour Suppressors or Oncoproteins
por: Jacquet, Karine, et al.
Publicado: (2021) -
Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer
por: Blondel, Alice, et al.
Publicado: (2019) -
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer
por: McClurg, Urszula L., et al.
Publicado: (2015)